The long road to leptin

Friedman, Jeffrey
December 2016
Journal of Clinical Investigation;Dec2016, Vol. 126 Issue 12, p4727
Academic Journal
journal article
Leptin is an adipose tissue hormone that functions as an afferent signal in a negative feedback loop that maintains homeostatic control of adipose tissue mass. This endocrine system thus serves a critical evolutionary function by protecting individuals from the risks associated with being too thin (starvation) or too obese (predation and temperature dysregulation). Mutations in leptin or its receptor cause massive obesity in mice and humans, and leptin can effectively treat obesity in leptin-deficient patients. Leptin acts on neurons in the hypothalamus and elsewhere to elicit its effects, and mutations that affect the function of this neural circuit cause Mendelian forms of obesity. Leptin levels fall during starvation and elicit adaptive responses in many other physiologic systems, the net effect of which is to reduce energy expenditure. These effects include cessation of menstruation, insulin resistance, alterations of immune function, and neuroendocrine dysfunction, among others. Some or all of these effects are also seen in patients with constitutively low leptin levels, such as occur in lipodystrophy. Leptin is an approved treatment for generalized lipodystrophy, a condition associated with severe metabolic disease, and has also shown potential for the treatment of other types of diabetes. In addition, leptin restores reproductive capacity and increases bone mineral density in patients with hypothalamic amenorrhea, an infertility syndrome in females. Most obese patients have high endogenous levels of leptin, in some instances as a result of mutations in the neural circuit on which leptin acts, though in most cases, the pathogenesis of leptin resistance is not known. Obese patients with leptin resistance show a variable response to exogenous leptin but may respond to a combination of leptin plus amylin. Overall, the identification of leptin has provided a framework for studying the pathogenesis of obesity in the general population, clarified the nature of the biologic response to starvation, and helped to advance our understanding of the neural mechanisms that control feeding.


Related Articles

  • A historical perspective on leptin. Coleman, Douglas L. // Nature Medicine;Oct2010, Vol. 16 Issue 10, p1097 

    In this article, the author discusses aspects of the connections between his earlier parabiosis experiments of mutant obese mice and the satiety factor leptin. The author states that the leptin, which controls adipose tissues mass in order to modulate appetite, has changed the prevailing theory...

  • Lessons from Leptin's Molecular Biology: Potential Therapeutic Actions of Recombinant Leptin and Leptin-Related Compounds. G. Correia, M. L.; Haynes, W. G. // Mini Reviews in Medicinal Chemistry;Jan2007, Vol. 7 Issue 1, p31 

    Leptin, a peptide secreted by the white adipose tissue, circulates to the central nervous system and signals the status of body energy stores, regulating feeding behavior and energy balance. As human obesity is characterized by hyperleptinemia and leptin resistance, increasing leptin sensitivity...

  • Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Kim, Ja-Young; van de Wall, Esther; Laplante, Mathieu; Azzara, Anthony; Trujillo, Maria E.; Hofmann, Susanna M.; Schraw, Todd; Durand, Jorge L.; Hua Li; Guangyu Li; Jelicks, Linda A.; Mehler, Mark F.; Hui, David Y.; Deshaies, Yves; Shulman, Gerald I.; Schwartz, Gary J.; Scherer, Philipp E.; Li, Hua; Li, Guangyu // Journal of Clinical Investigation;Sep2007, Vol. 117 Issue 9, p2621 

    Excess caloric intake can lead to insulin resistance. The underlying reasons are complex but likely related to ectopic lipid deposition in nonadipose tissue. We hypothesized that the inability to appropriately expand subcutaneous adipose tissue may be an underlying reason for insulin resistance...

  • Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation. Neuhofer, Angelika; Zeyda, Maximilian; Mascher, Daniel; Itariu, Bianca K.; Murano, Incoronata; Leitner, Lukas; Hochbrugger, Eva E.; Fraisl, Peter; Cinti, Saverio; Serhan, Charles N.; Stulnig, Thomas M. // Diabetes;Jun2013, Vol. 62 Issue 6, p1945 

    Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration, including insulin resistance and type 2 diabetes. Chronic inflammation may be a consequence of a failure to actively resolve inflammation and could result from...

  • Obesity and the Link between Metabolic Disorders. Dargan, Julie // Positive Health;Oct2015, Issue 225, p13 

    The article addresses the link between obesity and metabolic disorders. Topics discussed are the Slim Factor low-calorie-based diet, the role of fat in the body's metabolic function, the role of the hypothalamus in regulating autonomic body functions such as breathing, heartbeat and digestion,...

  • Insulin Resistance and Generalized Lipodystrophy Associated with Type 1 Diabetes: The Response to Leptin Therapy. Park, Jean Y.; Cochran, Elaine K.; Haller, Michael J.; Schatz, Desmond A.; Gorden, Phillip // Diabetes;Jun2007 Supplement 1, Vol. 56, pA165 

    Acquired generalized lipodystrophy (AGL) presents a major therapeutic challenge due to severe insulin resistance and hypertriglyceridemia. Several studies have demonstrated the dramatic clinical improvement seen with the administration of recombinant leptin for generalized lipodystrophy. Rarely,...

  • Human Recombinant Leptin Administration as a Potential Obesity Therapy. Masuo, Kazuko // Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry;Jun2010, Vol. 10 Issue 2, p50 

    No abstract available.

  • Establishment of Leptin-Responsive Cell Lines from Adult Mouse Hypothalamus. Iwakura, Hiroshi; Dote, Katsuko; Bando, Mika; Koyama, Hiroyuki; Hosoda, Kiminori; Kangawa, Kenji; Nakao, Kazuwa // PLoS ONE;2/5/2016, Vol. 11 Issue 2, p1 

    Leptin resistance is considered to be the primary cause of obesity. However, the cause of leptin resistance remains incompletely understood, and there is currently no cure for the leptin-resistant state. In order to identify novel drug-target molecules that could overcome leptin resistance, it...

  • Transgenic Overexpression of Leptin Rescues Insulin Resistance and Diabetes in a Mouse Model of Lipoatrophic Diabetes. Ebihara, Ken; Ogawa, Yoshihiro; Masuzaki, Hiroaki; Shintani, Mitsuyo; Miyanaga, Fumiko; Aizawa-Abe, Megumi; Kayashi, Tatsuya; Hosoda, Kiminori; Inoue, Gen; Yoshimasa, Yasunao; Gavrilova, Oksana; Reitman, Marc L.; Nakao, Kazuwa // Diabetes;Jun2001, Vol. 50 Issue 6, p1440 

    Focuses on the transgenic overexpression of leptin. Characteristics of lipoatrophic diabetes; Investigation of the pathophysiological and therapeutic roles of leptin in lipoatrophic diabetes; Benefits of leptin on lipoatrophic diabetes.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics